CRL Earnings
Charles River Laboratories next reports earnings on November 4, 2026. Track record: 4/4 beats.
Next Earnings In
Wednesday, November 4, 2026
Current Price
$291.50
EPS Estimate
Earnings Per Share
$2.95
+21.5% YoY
Trailing EPS
Last 12 months earnings
-$4.72
Beat Rate
4/4
100%Forward P/E
Price-to-Earnings ratio
23.0
Margin: -6.0%
Analyst Rating
14 analysts
Analyst Sentiment
Buy14 analystsTrading above average target while rated "Buy." Price may have rallied faster than analysts updated targets.
Earnings History
| Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| 2026-06-30 | $2.74 | $3.02 | +10.3% | Beat |
| 2026-03-31 | $1.95 | $2.06 | +5.4% | Beat |
| 2025-12-31 | $2.35 | $2.39 | +1.9% | Beat |
| 2025-09-30 | $2.34 | $2.43 | +3.9% | Beat |
Growth Estimates
| Period | EPS Est. | Revenue Est. | Growth |
|---|---|---|---|
| Current Qtr(0q) | $2.95 | $959M | +21.5% |
| Next Qtr(+1q) | $3.31 | $952.7M | +38.7% |
| Current Year(0y) | $11.32 | $3.9B | +10.1% |
| Next Year(+1y) | $12.69 | $4B | +12.1% |
Next Quarter Estimates
EPS Estimate
Earnings Per Share
$2.95
Revenue Estimate
$959M
Annual EPS Est.
$11.32
+10.1% YoY
CRL Earnings FAQ
When is CRL's next earnings date?
Charles River Laboratories (CRL) is expected to report earnings on November 4, 2026. The consensus EPS estimate is $2.95.
Does CRL usually beat earnings estimates?
Charles River Laboratories has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).
What is CRL's trailing EPS?
Charles River Laboratories's trailing twelve-month EPS is -$4.72. This is calculated from the last four quarters of reported earnings.
What do analysts think about CRL?
14 Wall Street analysts cover Charles River Laboratories. The consensus rating is "Buy" with an average price target of $281.00, implying 3.6% downside from the current price.